We are live on ! Find out more
AXN

Aoxing Pharmaceutical Company Inc.
AXN

Delisted

AXN was delisted on the 16th of October, 2017.

Back to rankings

3 hedge funds and large institutions have $12K invested in Aoxing Pharmaceutical Company Inc. in 2013 Q2 according to their latest regulatory filings, with 3 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
3
Holders Change
+3
Holders Change %
–
% of All Funds
0.1%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
CA
1
Cetera Advisors
Colorado
$7K +$7.15K +30,760 New
EWM
2
Evercore Wealth Management
New York
$3K +$3.06K +13,158 New
U
3
UBS
Switzerland
$2K +$1.99K +8,585 New

AXN Hedge Fund Activity: Q2 2013 in Review

3 of the 3,065 institutional investors tracked by Wall St. Rank reported a position in Aoxing Pharmaceutical Company Inc. (AXN) for Q2 2013, worth a combined $12K.

Buyers outnumbered sellers: 3 funds opened new AXN positions and 0 closed out — a net gain of 3 holders — while 0 added to existing stakes and 0 trimmed.

  • 3 institutional investors held Aoxing Pharmaceutical Company Inc. (AXN) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $12K of Aoxing Pharmaceutical Company Inc. stock for Q2 2013.
  • 3 funds opened new Aoxing Pharmaceutical Company Inc. positions in Q2 2013 and 0 closed out, a net change of +3 holders.

Based on aggregated 13F filings for Q2 2013.